Effect of PF-00734200 in Subjects With Type 2 Diabetes

Completed · Phase 2 · Has a placebo group

Conditions studied: Diabetes Mellitus, Type 2

In brief

To determine the effect of PF-00734200 on HbA1c in type 2 diabetic subjects receiving metformin

Key facts

Study ID

NCT00618007

Run by

Pfizer

People needed

289

Starts

2008-02-01

Expected to finish

2008-08-01

Last updated by the study team

2011-06-27

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men or women between 18-80 years of age with poorly controlled Type 2 diabetes

You may not qualify if…

• Type 1 or secondary forms of diabetes Currently using insulin

Where it is running

• Pfizer Investigational Site — Chandler, Arizona, United States
• Pfizer Investigational Site — Litchfield Park, Arizona, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Artesia, California, United States
• Pfizer Investigational Site — Cerritos, California, United States
• Pfizer Investigational Site — Fresno, California, United States
• Pfizer Investigational Site — Greenbrea, California, United States
• Pfizer Investigational Site — Huntington Beach, California, United States
• Pfizer Investigational Site — Los Angeles, California, United States
• Pfizer Investigational Site — National City, California, United States
• Pfizer Investigational Site — Roseville, California, United States
• Pfizer Investigational Site — Valley Village, California, United States
• Pfizer Investigational Site — West Covina, California, United States
• Pfizer Investigational Site — DeFuniak Springs, Florida, United States
• Pfizer Investigational Site — Jacksonville, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — Miami, Florida, United States
• Pfizer Investigational Site — New Port Richey, Florida, United States
• Pfizer Investigational Site — Ocala, Florida, United States
• Pfizer Investigational Site — Pinecrest, Florida, United States
• Pfizer Investigational Site — St. Petersburg, Florida, United States
• Pfizer Investigational Site — Conyers, Georgia, United States
• Pfizer Investigational Site — Idaho Falls, Idaho, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.